BAL PHARMA LTD.

Scale -

PBT is 1.14 Rs Cr; Annual Growth is 15 %; 5 Year CAGR is -10 %

PAT is 6.32 Rs Cr; Continuous Decline over 3 years

Profitability -

PBDIT Margin is 10.85 %; Continuous Growth over 3 years

PAT Margin is 2.02 %; Annual Decline is -15 %
Quarterly Profit margin is 1 %; in Bottom Quartile

Return -

ROA is 1.67 %; Annual Decline is -22 %; Continuous Decline over 3 years
ROCE is 18 %; Continuous Decline over 3 years
ROE is 7.61 %; Continuous Decline over 3 years
Asset Turnover is 88 %; Continuous Decline over 3 years

Efficiency -

Operating cash flow is 30.84 Rs Cr; Annual Growth is 52 %

Current Ratio is 1.05; Continuous Decline over 3 years; in Bottom Quartile
Quick Ratio is 0.59; Continuous Decline over 3 years; in Bottom Quartile
Inventory Turnover Ratio is 2.84; in Bottom Quartile

Solvancy -

Contingent Liabilities is 5.58 Rs Cr; Annual Decline is -67 %
Debt/Equity is 1.93; Continuous Decline over 3 years; in Top Quartile

Total Debt is 160 Rs Cr; Continuous Growth over 3 years; in Top Quartile
Long term Debt is 31.88 Rs Cr; in Top Quartile

Quality -

Operating cashflow/ebitda is 91 %; Annual Growth is 42 %; in Top Quartile
Operating cashflow/PAT is 488 %; Annual Growth is 74 %; in Top Quartile
Change in Inventories/Total Expenses is -4 %; Annual Decline is -69 %; Continuous Decline over 3 years; in Bottom Quartile
Current Tax/PAT is 0 %; in Bottom Quartile

Other Expenses/Total Expenses is 18 %; Continuous Growth over 3 years
Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: